Combination Therapy Appears More Effective Than Single Drug for Treating Men With Lower Urinary Tract Symptoms
Thursday, 16 November 2006
BERKELEY, CA (UroToday.com) - Men with overactive bladder and lower urinary tract symptoms who received a combination therapy were more likely to report improvement in symptoms than men who received only one medication, according to a study in the November 15 issue of JAMA, a theme issue on men's health.
read more
|
A Double-Blind, Randomized Controlled Trial of Cystometry Using Saline Versus 0.3 M Potassium Chloride Infusion in Women with Overactive Bladder Syndrome
Friday, 03 November 2006
BERKELEY, CA (UroToday.com) - Philip and colleagues from Cheshire, UK undertook a double blind, prospective randomized controlled trial of cystometry using normal saline (NS) and 0.3M potassium chloride (KCl) in an attempt to clarify the effect of potassium chloride on both bladder sensitivity and filling.
read more
|
European Urology - The Current and Future Burden and Cost of Overactive Bladder in Five European Countries
Wednesday, 25 October 2006
Volume 50, Issue 5, Pages 1050-1057 (November 2006) Abstract - Objective: To estimate and compare the current and future direct cost of overactive bladder (OAB) to the health care systems of five European countries.
read more
|
European Urology - Histologic Features in the Urinary Bladder Wall Affected from Neurogenic Overactivity—A Comparison of Inflammation, Oedema and Fibrosis With and Without Injection of Botulinum Toxin Type A
Wednesday, 25 October 2006
Volume 50, Issue 5, Pages 1058-1064 (November 2006) Abstract - Objectives: To study histological features and morphological differences in bladder wall specimen from patients with and without botulinum toxin A injections and to compare those issues in responders and non-responders to the toxin therapy.
read more
|
Diagnostic Ultrasound Updates Company Name to Verathon Inc.
Monday, 16 October 2006
BOTHELL, WA (Press Release) October 11, 2006 - Today Diagnostic Ultrasound Corporation updated its company name to Verathon Inc.
read more
|
EGF and HB-EGF Modulate Inward Potassium Current in Human Bladder Urothelial Cells from Normal and Interstitial Cystitis Patients
Monday, 09 October 2006
BERKELEY, CA (UroToday.com) - There are currently two well-known bladder hypersensory syndromes - overactive bladder (OAB) and interstitial cystitis (BPS/IC). Because BPS/IC is associated with chronic bladder pain, it represents potentially a more challenging clinical problem. There are no treatments that target specifically the bladder sensory pathways.
read more
|
European Urology - Botulinum Toxin Injections for Neurogenic and Idiopathic Detrusor Overactivity: A Critical Analysis of Results
Monday, 02 October 2006
Volume 50, Issue 4, Pages 684-710 (October 2006) Abstract - Objective:In recent years there has been an increasing use of the botulinum neurotoxins for the management of conditions characterised by detrusor overactivity. Early studies showed promising results in an area where few options previously existed between pharmacotherapy and surgery.
read more
|
European Urology - Successful Treatment with Intradetrusor Botulinum-A Toxin for Urethral Urinary Leakage (Catheter Bypassing) in Patients with End-Staged Multiple Sclerosis and Indwelling Suprapubic Catheters
Monday, 02 October 2006
Volume 50, Issue 4, Pages 806-810 (October 2006) Abstract -
Objective:
To present the initial results of Botulinum-A toxin (BTA) injection in patients with long-standing multiple sclerosis (MS) and urethral leakage of urine in spite of indwelling suprapubic catheters (catheter bypassing).
read more
|
European Urology - Determinants of Seeking of Primary Care for Lower Urinary Tract Symptoms: The Krimpen Study in Community-Dwelling Men
Monday, 02 October 2006
Volume 50, Issue 4, Pages 811-817 (October 2006) 1. Introduction With the growth in diagnostic and therapeutic opportunities in health care, and as workforce and time resources become scarce, the efficiency of health care is followed critically [1].
read more
|
BJUI Mini Reviews - The Management of Neurogenic Bladder and Quality of Life in Spinal Cord Injury
Monday, 02 October 2006
Login to read more...
|
Expert Comments on the Developments in the Pharmacological Therapy for Overactive Bladder
Thursday, 28 September 2006
BERKELEY, CA (UroToday.com) - In a recent review in the October 2006 supplement of BJU Int., Alan J. Wein, Professor and Chairman of Urology at The University of Pennsylvania, comments on the developments in the pharmacological management of the overactive bladder.
read more
|
BJUI Mini Reviews - Antimuscarinic Drugs in Detrusor Overactivity and the Overactive Bladder Syndrome: Motor or Sensory Actions?
Saturday, 02 September 2006
Login to read more...
|
European Urology - Antimuscarinics and Cognitive Function
Monday, 07 August 2006
De Ridder DEuropean UrologyAugust 2006 (Vol. 50, Issue 2, Pages 211-212) Published online 24 April 2006
read more
|
European Urology - Differential Effects of the Antimuscarinic Agents Darifenacin and Oxybutynin ER on Memory in Older Subjects
Friday, 04 August 2006
Kay G, Crook T, Rekeda L, Lima R, Ebinger U, Arguinzoniz M, Steel MEuropean UrologyAugust 2006 (Vol. 50, Issue 2, Pages 317-326) Published online 24 April 2006
read more
|
Women With Urodynamic Stress Incontinence Are More Likely To Leak With Coughing, While Those With Detrusor Overactivity Are More Likely To Leak With Valsalva
Wednesday, 28 June 2006
BERKELEY, CA (UroToday.com) - Valsalva (VLPP) and cough (CLPP) leak point pressures have been used for evaluating urinary incontinence in women. The relationship between these leak point pressures and stress urinary incontinence and detrusor overactivity is not known. Drs. Singha, Nallaswany and Arunkalaivnan from Birmingham, United Kingdom performed a prospective study to evaluate this relationship.
read more
|
Overactive Bladder (OAB) 
